Get the Stockscreener App
161.40
2.82%
4.42
After Hours:
161.40
Davita Inc stock is traded at $161.40, with a volume of 987.48K.
It is up +2.82% in the last 24 hours and down -0.35% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.
See More
Previous Close:
$156.98
Open:
$157.12
24h Volume:
987.48K
Relative Volume:
1.29
Market Cap:
$13.19B
Revenue:
$12.67B
Net Income/Loss:
$827.68M
P/E Ratio:
32.09
EPS:
5.03
Net Cash Flow:
$1.42B
1W Performance:
+2.62%
1M Performance:
-0.35%
6M Performance:
+14.52%
1Y Performance:
+65.49%
1-Day Range:
$156.86
$161.89
1-Week Range:
$154.05
$161.89
52-Week Range:
$97.31
$168.50
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| DVA | 161.40 | 13.19B | 12.67B | 827.68M | 1.42B | 5.03 |
| HCA | 333.00 | 83.79B | 69.62B | 5.93B | 5.88B | 20.33 |
| THC | 151.84 | 14.83B | 20.97B | 3.13B | 2.39B | 4.33 |
| UHS | 197.52 | 13.03B | 15.42B | 1.03B | 956.84M | 9.53 |
| FMS | 21.79 | 12.79B | 20.87B | 715.19M | 2.10B | 0.8156 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
When Should You Buy DaVita Inc. (NYSE:DVA)? - Yahoo Finance
Is Wall Street Bullish or Bearish on DaVita Stock? - MSN
DaVita Inc. (NYSE:DVA) Shares Sold by Principal Financial Group Inc. - MarketBeat
$3.8M DaVita data privacy class action settlement - Top Class Actions
ING Groep NV Trims Position in DaVita Inc. (NYSE:DVA) - MarketBeat
Alkermes, DaVita, Jabil, Ralph Lauren, among potential M&A candidatesBofA - Seeking Alpha
Is Wall Street Bullish Or Bearish On DaVita Stock? - Barchart
DaVita Inc. (NYSE:DVA) Shares Sold by Mount Lucas Management LP - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. (NYSE:DVA) Shares Bought by KBC Group NV - MarketBeat
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation (NYSE:DVA) - Seeking Alpha
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates - Benzinga
DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call - Quantisnow
Is DaVita Inc. (NYSE:DVA) Potentially Undervalued? - Simply Wall St
Chase Investment Counsel Corp Buys 11,912 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
Los Angeles Capital Management LLC Acquires 20,022 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Sold by Amalgamated Bank - MarketBeat
DaVita To Present At UBS Global Healthcare Conference 2024; Webcast At 3:30 PM ET - Nasdaq
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - PR Newswire
Versor Investments LP Purchases Shares of 7,179 DaVita Inc. (NYSE:DVA) - MarketBeat
Crossmark Global Holdings Inc. Has $4.23 Million Stock Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
Janney Montgomery Scott LLC Raises Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 - The Malaysian Reserve
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
May 2025 Options Now Available For DaVita (DVA) - Nasdaq
Why DaVita Stock Withered on Wednesday - MSN
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
DaVita Inc. Reports Strong Q3 2024 Performance - MSN
DaVita's SWOT analysis: healthcare giant's stock faces regulatory shifts - Investing.com India
DaVita's SWOT analysis: healthcare giant's stock faces regulatory shifts By Investing.com - Investing.com Canada
DaVita Inc. (NYSE:DVA) Q3 2024 Earnings Call Transcript - MSN
New York State Teachers Retirement System Has $9.02 Million Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
Raymond James & Associates Raises Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up - MSN
DaVita Inc. (NYSE:DVA) Receives $161.80 Consensus Target Price from Brokerages - MarketBeat
DaVita (DVA) Shares Plummet Following Disappointing Earnings Rep - GuruFocus.com
DaVita price target raised to $164 from $150 at Barclays - TipRanks
DaVita Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
International Assets Investment Management LLC Invests $10.35 Million in DaVita Inc. (NYSE:DVA) - MarketBeat
Earnings call: DaVita maintains guidance despite headwinds and hurricanes - Investing.com India
Earnings call: DaVita maintains guidance despite headwinds and hurricanes By Investing.com - Investing.com Canada
DaVita (NYSE:DVA) Announces Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat
DaVita is Now Oversold (DVA) - Nasdaq
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus.com
DaVita (NYSE:DVA) Shares Gap Down Following Weak Earnings - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
DaVita Inc (DVA) Q3 2024 Earnings Call Highlights: Strong Financial Performance Amid ... - Yahoo Finance
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):